In multiple sclerosis “mimics”—NMOSD and MOGAD—especially in the individuals that are seronegative for the specific autoantibodies (AQP4 and MOG-Ab), according to researchers, NfL levels do not represent a useful tool in the differential diagnosis. The gene discussed is NEFL; the disease is multiple sclerosis.